RIV Capital Partners With Cannabis Wholesale Platform Nabis To Boost New York Distribution

Zinger Key Points
  • Nabis's technology will facilitate distribution for RIV Capital branded products to licensed retailers across New York state.
  • The partnership follows recently acquired approval for the merger between RIV Capital and Cansortium.

RIV Capital Inc. RIV CNPOF announced a distribution partnership agreement Wednesday with cannabis wholesale platform Siban Holdings, Inc. (“Nabis”). Under the agreement, Nabis’s technology and expertise will facilitate distribution for the company’s branded products to licensed retailers across New York.

“As we bring in exciting new brands like MOODS and the market here expands, we are thrilled to begin our partnership with Nabis to help broaden our reach in New York,” stated Dave Vautrin, chief retail officer and interim chief executive officer of RIV Capital. “This agreement will allow us to achieve efficiencies within our expense profile and remove unnecessary complexity from our organization while opening up new opportunities to sell our premium, high-quality branded products to both medical patients and adult-use consumers alike in New York.”

The partnership leverages Nabis’s experience in servicing over 300 brands nationwide with professional data analytics, financing, sales and marketing services. RIV expects to substantially expand its wholesale network and offer an enhanced product portfolio to a rapidly growing number of dispensaries and delivery businesses across New York.

Read Also: Cannabis Debt Looms For These Weed Giants: Here’s How Some Tackled Their Financial Challenges

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

New York's Cannabis Market Growth

The agreement follows recent approval from the New York Cannabis Control Board for the merger between RIV Capital and Cansortium CNTMF. The merger, expected to close by the end of 2024, positions the combined company to take full advantage of covering 25% of the U.S. population with eight cultivation and processing facilities and 42 retail dispensaries.

The legal New York cannabis market has improved significantly as action by state authorities have cracked down on illicit market activities and expanded the legal market. The New York State Cannabis Advisory Board recently reported that Q3 2024 total adult-use sales reached $250 million, representing 54% sequential growth and an increase of 357% from a year earlier.

Vince C. Ning, co-founder and CEO of Nabis, commented, “We are excited to be supporting RIV Capital and to be working alongside Dave Vautrin again. I witnessed first-hand Dave’s strong leadership as friendly former competitors in California when he ran California’s largest distribution business, Continuum by Origin House, before it was sold to Cresco and returned to his native state of New York. The RIV Capital team’s desire to focus on their core expertise in cultivation and retail, and entrusting Nabis’ technology platform for wholesaling, is a testament to their deep experience and foresight in understanding the requirements to scale their burgeoning wholesale business.”

CNPOF Price Action

RIV Capital shares closed Wednesday's market session flat at $0.14 per share.

Read Next:

Image via Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.